Nortrachelogenin Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor Kappa-B Signaling and Osteoclastogenesis
Drug Research · 03.09.2026 · 76 (08/09) · 243-245
DOI: 10.1055/a-2943-0950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 03.09.2026. Verfasst von Lifang Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou-Kean University, Department of Biology, China, Wenzhou. Hauptthemen laut MEDLINE: Osteoclasts, Signal Transduction, RANK Ligand, NF-kappa B. Die Arbeit nennt 15 Literaturangaben. Gefördert von: International Frontier Interdisciplinary Research Institute of Wenzhou-Kean University (IFIRI-WKU), Wenzhou-Kean University.
Abstract (Originalsprache)
Nortrachelogenin is a dibenzylbutyrolactone lignan associated with redox-sensitive signaling. We examined its effects on receptor activator of nuclear factor kappa-B ligand (RANKL)-induced nuclear factor kappa-B (NF-κB) activation in osteoclast precursors. Nortrachelogenin attenuated IκB phosphorylation and degradation and reduced p65 phosphorylation. Consistently, it markedly decreased the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclasts. These findings identify nortrachelogenin as a lignan scaffold that suppresses nuclear factor kappa-B signaling and osteoclastogenesis in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wenzhou-Kean University, Department of Biology, China, Wenzhou.
- Kean University, Dorothy and George Hennings College of Science, Mathematics and Technology, United States, Union.
- Harcourt Butler Technical University, Department of Chemistry, India, Kanpur.
- International Frontier Interdisciplinary Research Institute (IFIRI), Wenzhou-Kean University, Zhejiang, China, Wenzhou.
ORCID-Profile: Vishwa Deepak
Förderung
- International Frontier Interdisciplinary Research Institute of Wenzhou-Kean University (IFIRI-WKU)
- Wenzhou-Kean University
Zitieren
APA
Zhang, L., Basit, F., Kumar, S., & Deepak, V. (2026). Nortrachelogenin Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor Kappa-B Signaling and Osteoclastogenesis. Drug Research, 76(08/09), 243-245. https://doi.org/10.1055/a-2943-0950
Vancouver
Zhang L, Basit F, Kumar S, Deepak V. Nortrachelogenin Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor Kappa-B Signaling and Osteoclastogenesis. Drug Research. 2026;76(08/09):243-245. doi:10.1055/a-2943-0950
BibTeX
@article{Zhang2026,
author = {Zhang, Lifang and Basit, Farwa and Kumar, Santosh and Deepak, Vishwa},
title = {Nortrachelogenin Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor Kappa-B Signaling and Osteoclastogenesis},
journal = {Drug Research},
year = {2026},
volume = {76},
number = {08/09},
pages = {243--245},
doi = {10.1055/a-2943-0950}
}
EUVIMED